Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m
CRISPR/Cas9 is a gene-editing technology that allows scientists to precisely cut and modify DNA in living organisms. Credit: Prostock-studio via...
deal
CRISPR/Cas9 is a gene-editing technology that allows scientists to precisely cut and modify DNA in living organisms. Credit: Prostock-studio via...
